Publications des scientifiques de l'IRD

Latire T., Legendre F., Bouyoucef M., Marin Frédéric, Carreiras F., Rigot-Jolivet M., Lebel J. M., Galera P., Serpentini A. (2017). Shell extracts of the edible mussel and oyster induce an enhancement of the catabolic pathway of human skin fibroblasts, in vitro. Cytotechnology, 69 (5), p. 815-829. ISSN 0920-9069.

Titre du document
Shell extracts of the edible mussel and oyster induce an enhancement of the catabolic pathway of human skin fibroblasts, in vitro
Année de publication
2017
Type de document
Article référencé dans le Web of Science WOS:000410704400007
Auteurs
Latire T., Legendre F., Bouyoucef M., Marin Frédéric, Carreiras F., Rigot-Jolivet M., Lebel J. M., Galera P., Serpentini A.
Source
Cytotechnology, 2017, 69 (5), p. 815-829 ISSN 0920-9069
Mollusc shells are composed of more than 95% calcium carbonate and less than 5% organic matrix consisting mostly of proteins, glycoproteins and polysaccharides. In this study, we investigated the effects of matrix macromolecular components extracted from the shells of two edible molluscs of economic interest, i.e., the blue mussel Mytilus edulis and the Pacific oyster Crassostrea gigas. The potential biological activities of these organic molecules were analysed on human dermal fibroblasts in primary culture. Our results demonstrate that shell extracts of the two studied molluscs modulate the metabolic activities of the cells. In addition, the extracts caused a decrease of type I collagen and a concomitant increase of active MMP-1, both at the mRNA and the protein levels. Therefore, our results suggest that shell extracts from M. edulis and C. gigas contain molecules that promote the catabolic pathway of human dermal fibroblasts. This work emphasises the potential use of these shell matrices in the context of anti-fibrotic strategies, particularly against scleroderma. More generally, it stresses the usefulness to valorise bivalve shells that are coproducts of shellfish farming activity.
Plan de classement
Substances naturelles [035] ; Santé : généralités [050]
Localisation
Fonds IRD [F B010071019]
Identifiant IRD
fdi:010071019
Contact